Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1

Immunology Letters

Volumn 104, Issue 1-2, 2006, Pages 83-88

  Kis, Loránd L ^a   Takahara, Miki ^a   Nagy, Noémi ^a   Klein, George ^a   Klein, Eva ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Epstein Barr virus; Hodgkin lymphoma; LMP 1

Indexed keywords

CD40 LIGAND; CYTOKINE; EPSTEIN BARR VIRUS ENCODED NUCLEAR ANTIGEN 1; EPSTEIN BARR VIRUS ENCODED NUCLEAR ANTIGEN 2; EPSTEIN BARR VIRUS ENCODED NUCLEAR ANTIGEN 3; EPSTEIN BARR VIRUS ENCODED NUCLEAR ANTIGEN 4; EPSTEIN BARR VIRUS ENCODED NUCLEAR ANTIGEN 5; EPSTEIN BARR VIRUS ENCODED NUCLEAR ANTIGEN 6; INTERLEUKIN 10; INTERLEUKIN 4; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2; LATENT MEMBRANE PROTEIN 2A; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS PROTEIN;

B LYMPHOCYTE; BURKITT LYMPHOMA; CELLULAR IMMUNITY; CONFERENCE PAPER; EPSTEIN BARR VIRUS; FUNCTIONAL PROTEOMICS; GENE EXPRESSION; GENETIC CODE; HODGKIN DISEASE; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOMA CELL LINE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; VIRUS CARRIER; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS INFECTION;

B-LYMPHOCYTES; CYTOKINES; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; VIRAL MATRIX PROTEINS; VIRUS LATENCY;

EID: 33644679020     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2005.11.003     Document Type: Conference Paper

References (54)

1. A.B. Rickinson, and E. Kieff Epstein-Barr virus D.M. Knipe PM. Howley Fields virology 2001 Lippincott Williams and Wilkins Philadelphia 2575 2628
2. E. Kieff, and A.B. Rickinson Epstein-Barr virus and its replication D.M. Knipe PM. Howley Fields virology 2001 Lippincott Williams and Wilkins Philadelphia 2511 2574
3. G.J. Babcock, L.L. Decker, M. Volk, and D.A. Thorley-Lawson EBV persistence in memory B cells in vivo Immunity 9 1998 395 404
4. I. Anagnostopoulos, M. Hummel, C. Kreschel, and H. Stein Morphology, immunophenotype and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus Blood 85 1995 744 750
5. J. Kurth, M.L. Hansmann, K. Rajewsky, and R. Kuppers Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction Proc Natl Acad Sci USA 100 2003 4730 4735
6. A.M. Joseph, G.J. Babcock, and D.A. Thorley-Lawson Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils J Virol 74 2000 9964 9971
7. R.J. Tierney, N. Steven, L.S. Young, and A.B. Rickinson Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state J Virol 68 1994 7374 7385
8. D. Hochberg, J.M. Middeldorp, M. Catalina, J.L. Sullivan, K. Luzuriaga, and D.A. Thorley-Lawson Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo Proc Natl Acad Sci USA 101 2004 239 244
9. I. Araujo, H.D. Foss, M. Hummel, I. Anagnostopoulos, H.S. Barbosa, and A. Bittencourt Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma J Pathol 187 1999 326 330
10. M.G. Horenstein, R.G. Nador, A. Chadburn, E.M. Hyjek, G. Inghirami, and D.M. Knowles Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 Blood 90 1997 1186 1191
11. L. Szekely, F. Chen, N. Teramoto, B. Ehlin-Henriksson, K. Pokrovskaja, and A. Szeles Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line J Gen Virol 79 1998 1445 1452
12. G.J. Babcock, D. Hochberg, and D.A. Thorley-Lawson The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell Immunity 13 2000 497 506
13. E.M. Deacon, G. Pallesen, G. Niedobitek, J. Crocker, L. Brooks, and A.B. Rickinson Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells J Exp Med 17 1993 339 349
14. L. Young, C. Alfieri, K. Hennessy, H. Evans, C. O'Hara, and K.C. Anderson Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease N Engl J Med 321 1989 1080 1085
15. M. Rowe, D.T. Rowe, C.D. Gregory, L.S. Young, P.J. Farrell, and H. Rupani Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells EMBO J 6 1987 2743 2751
16. G. Niedobitek, A. Agathanggelou, H. Herbst, L. Whitehead, D.H. Wright, and L.S. Young Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells J Pathol 182 1997 151 159
17. J.J. Oudejans, M. Jiwa, A.J. van den Brule, F.A. Grasser, A. Horstman, and W. Vos Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders Am J Pathol 147 1995 923 933
18. N. Teramoto, P. Gogolak, N. Nagy, A. Maeda, K. Kvarnung, and T. Bjorkholm Epstein-Barr virus-infected B-chronic lymphocyte leukemia cells express the virally encoded nuclear proteins but they do not enter the cell cycle J Hum Virol 3 2000 125 136
19. G. Kelly, A. Bell, and A. Rickinson Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2 Nat Med 8 2002 1098 1104
20. M.D. Jones, L. Foster, T. Sheedy, and B.E. Griffin The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus EMBO J 3 1984 813 821
21. M. Rabson, L. Gradoville, L. Heston, and G. Miller Nonimmortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye J Virol 44 1982 834 844
22. K.M. Kaye, K.M. Izumi, and E. Kieff Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation Proc Natl Acad Sci USA 90 1993 9150 9154
23. D. Panagopoulos, P. Victoratos, M. Alexiou, G. Kollias, and G. Mosialos Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo J Virol 78 2004 13253 13261
24. R. Dalla-Favera, A. Migliazza, C.C. Chang, H. Niu, L. Pasqualucci, and M. Butler Molecular pathogenesis of B cell malignancy: the role of BCL-6 Curr Top Microbiol Immunol 246 1999 257 263
25. L.L. Kis, N. Nagy, G. Klein, and E. Klein Expression of SH2D1A in five classical Hodgkin's disease-derived cell lines Int J Cancer 104 2003 658 661
26. L.L. Kis, J. Nishikawa, M. Takahara, N. Nagy, L. Matskova, and K. Takada The in vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1; CD40-ligand and IL-4 induces LMP-1 but not EBNA-2 Int J Cancer 113 2005 937 945
27. L. Cuomo, P. Trivedi, P.O. de Campos-Lima, Q.J. Zhang, E. Ragnar, and G. Klein Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines Mol Immunol 30 1993 441 450
28. C.B. Hertel, X.G. Zhou, S.J. Hamilton-Dutoit, and S. Junker Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed Sternberg cells of classical Hodgkin lymphoma Oncogene 21 2002 4908 4920
29. R. Tierney, H. Kirby, J. Nagra, A. Rickinson, and A. Bell The Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5 J Virol 74 2000 10458 10467
30. B. Contreras-Brodin, A. Karlsson, T. Nilsson, L. Rymo, and G. Klein B cell-specific activation of the Epstein-Barr virus-encoded C promoter compared with the wide-range activation of the W promoter J Gen Virol 77 1996 1159 1162
31. I. Schwering, A. Brauninger, U. Klein, B. Jungnickel, M. Tinguely, and V. Diehl Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma Blood 101 2003 1505 1512
32. E. Anastasiadou, F. Boccellato, M. Cirone, L.L. Kis, E. Klein, and L. Frati Epigenetic mechanisms do not control viral latency III in primary effusion lymphoma cells infected with a recombinant Epstein-Barr virus Leukemia 19 2005 1854 1856
33. M. Arguello, M. Sgarbanti, E. Hernandez, Y. Mamane, S. Sharma, and M. Servant Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines Oncogene 22 2003 964 973
34. B.A. Contreras-Brodin, M. Anvret, S. Imreh, E. Altiok, G. Klein, and M.G. Masucci B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids J Gen Virol 72 1991 3025 3033
35. R. Kuppers Molecular biology of Hodgkin's lymphoma Adv Cancer Res 84 2002 277 312
36. B.F. Skinnider, and T.W. Mak The role of cytokines in classical Hodgkin lymphoma Blood 99 2002 4283 4297
37. A. Carbone, A. Gloghini, H.J. Gruss, and A. Pinto CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease Am J Pathol 147 1995 912 922
38. Kis LL, Takahara M, Nagy N, Klein G, Klein E. IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B-lymphocytes, in Burkitt lymphoma-, and in NK-lymphoma derived cell lines. Blood; Dec. 2005, in press.
39. D.A. Thorley-Lawson Epstein-Barr virus: exploiting the immune system Nat Rev Immunol 1 2001 75 82
40. Y.J. Liu, and J. Banchereau Regulation of B-cell commitment to plasma cells or to memory B cells Semin Immunol 9 1997 235 240
41. H. Kanzler, R. Kuppers, M.L. Hansmann, and K. Rajewsky Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumour clone derived from (crippled) germinal center B cells J Exp Med 184 1996 1495 1505
42. Mancao C, Altmann M, Jungnickel B, Hammerschmidt W. Rescue of 'crippled' germinal center B cells from apoptosis by Epstein-Barr virus. Blood 2005;August:2 [epub ahead of print].
43. Chaganti S, Bell AI, Begue-Pastor N, Milner AE, Drayson M, Gordon J, et al. Epstein-Barr virus infection in vitro can rescue germinal centre B cells with inactivated immunoglobulin genes. Blood 2005;August;25 [epub ahead of print].
44. Bechtel D, Kurth J, Unkel C, Kuppers R. Transformation of BCR-deficient germinal center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and post transplant lymphoma. Blood 2005;August;30 [epub ahead of print].
45. R.C. Bargou, F. Emmerich, D. Krappmann, K. Bommert, M.Y. Mapara, and W. Arnold Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells J Clin Invest 100 1997 2961 2969
46. E. Cabannes, G. Khan, F. Aillet, R.F. Jarrett, and R.T. Hay Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha Oncogene 18 1999 3063 3070
47. B. Jungnickel, A. Staratschek-Jox, A. Brauninger, T. Spieker, J. Wolf, and V. Diehl Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma J Exp Med 191 2000 395 402
48. J.I. Martin-Subero, S. Gesk, L. Harder, T. Sonoki, P.W. Tucker, and B. Schlegelberger Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma Blood 99 2002 1474 1477
49. R. Horie, T. Watanabe, Y. Morishita, K. Ito, T. Ishida, and Y. Kanegae Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells Oncogene 21 2002 2493 2503
50. R.G. Caldwell, J.B. Wilson, S.J. Anderson, and R. Longnecker Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals Immunity 9 1998 405 411
51. F. Scholle, K.M. Bendt, and N. Raab-Traub Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt J Virol 74 2000 10681 10689
52. T. Frisan, J. Sjoberg, R. Dolcetti, M. Boiocchi, V. De Re, and A. Carbone Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease Blood 86 1995 1493 1501
53. E. Maggio, A. van den Berg, A. Diepstra, J. Kluiver, L. Visser, and S. Poppema Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues Ann Oncol 13 2002 52 56
54. N.A. Marshall, L.E. Christie, L.R. Munro, D.J. Culligan, P.W. Johnston, and R.N. Barker Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma Blood 103 2004 1755 1756